Revisiting the issue of access to medicines in Africa: Challenges and recommendations

Abstract

Background: Access to safe, effective, affordable, and quality medicines is an essential component of the right to health and is also one of the targets in the global development agenda. In this review article, we extensively discuss the challenges and issues surrounding access to medicines in the African region as well as provides recommendations for ensuring medicines security on the continent. Methods: We conducted narrative review with the use of data reported in published literature, reports, and grey literature available in African countries on topics pertaining access to medicines. The authors also snowballed further data to gather information for this review and narrative synthesis was conducted. Results: Africa faces a double burden of infectious and non-communicable diseases and the need for effective universal access to medicines cannot be deemphasized. However, access to medicines on the continent is not without issues and challenges. Some of which are the high burden of infectious diseases and non-infectious diseases, limited pharmaceutical industries and high costs of raw materials, overdependence on countries abroad for medicines, poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health financing mechanisms, lack of infrastructures and technical know-how, low investment on research and development, and circulation of fake and counterfeit medicines among others. Conclusion:This review reifies that access to medicines in Africa faces numerous challenges and it emphasizes the urgent need to address these issues as the continent geared towards strengthening its health systems for universal health coverage.

Improving the availability of prescription drugs in Lebanon: a critical analysis of alternative policy options

“…Inspection efforts by the Ministry of Public Health would need to be bolstered to discourage smuggling by distributors and pharmacists. Evidence shows that the lack of a functioning and sustainable drug supply chain is a major reason for poor access to essential drugs [ 53 ].…”

African Medicines Agency: How it will change the landscape of medicines in Africa

“…Access to medicines and healthcare also remains challenging in Africa due to dependency on Western donor funding grounded on weak sustainable health financing, thus limiting the optimization of quality health among the vast majority [7]. This dependency was exposed during the advent of COVID‐19 and the Ebola outbreak, revealing the vulnerability and risk of the continent's reliance [8].…”

Market violence through destructive entrepreneurship: Assessing institutional responses to the proliferation of counterfeit traditional and alternative medicines in Ghana

“…TAM such as herbal medicines play a significant role in the public health architecture of emerging economies. Close to 80% of Africa's 1.4 billion inhabitants make use of TAM [ 3 ]. While the figure for fake TAM may not be known (albeit a growing phenomenon), the WHO has reported that Africa alone accounts for 42% of all global cases of counterfeit and substandard medicines [ 4 ].…”